Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Xtant Medical Holdings, Inc.
Bear Case (25th pct.)
22.2% vs price
Base Case (Median)
36.9% vs price
Bull Case (75th pct.)
105.4% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $0.43 | 5.2% | High (40%) |
| EV/EBITDA | $1.13 | 175.7% | Medium (20%) |
| Earnings Power Value | $0.56 | 37.4% | Medium (50%) |
Based on 3 out of 8 methods, XTNT appears undervalued at the current price of $0.41. The base case fair value of $0.56 implies 36.9% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.